Related Experiment Video
Updated: Jun 21, 2025
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
2.3K
TGF-β-Based Therapies for Treating Ocular Surface Disorders.
Fernando T Ogata1, Sudhir Verma1,2, Vivien J Coulson-Thomas1
1College of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.
Cells
|July 12, 2024
Summary
Transforming Growth Factor-Beta (TGF-β) is vital for corneal wound healing, promoting repair but potentially causing scarring with excessive levels. Understanding its isoforms (TGF-β1-3) is key for therapeutic development.
Area of Science:
- Ophthalmology
- Cell Biology
- Regenerative Medicine
Background:
- Corneal injuries require effective healing mechanisms for structural and functional restoration.
- Transforming Growth Factor-Beta (TGF-β) is a critical signaling molecule in corneal wound repair.
- Dysregulation of TGF-β is implicated in corneal pathologies like scarring and Peter's Anomaly.
Purpose of the Study:
- To summarize the complex roles of TGF-β isoforms in corneal wound healing.
- To dissect the molecular and cellular mechanisms of TGF-β in corneal regeneration.
- To explore TGF-β's involvement in corneal pathogenesis and potential therapeutic strategies.
Main Methods:
- Review of existing literature on TGF-β signaling in corneal wound healing.
- Analysis of TGF-β isoform-specific functions (TGF-β1, TGF-β2, TGF-β3).
- Examination of TGF-β's role in cellular processes like migration, proliferation, and differentiation.
Main Results:
- TGF-β signaling is essential for initiating corneal repair processes, including cell migration and myofibroblast differentiation.
- While crucial for closure, elevated TGF-β levels can lead to detrimental fibrosis and vision-impairing scarring.
- Distinct roles of TGF-β1, TGF-β2, and TGF-β3 contribute to the complexity of corneal healing.
Conclusions:
- Targeting TGF-β pathways offers potential for therapeutic interventions in corneal wound healing and disease.
- A comprehensive understanding of TGF-β mechanisms is necessary for developing effective treatments for corneal pathologies.
- Further research into TGF-β isoform-specific actions can refine therapeutic approaches for vision restoration.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
01:28Angle Closure Glaucoma: Treatment
470
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
470
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
128
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
128
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
114
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
114
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:25Glaucoma: Overview
538
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
538